p¼0.005). In accordance, ELISA analysis confirmed these data.Finally, in endotoxemic renal biopsies, we observed an increase of CD133 þ ARPCs that expressed BPIFA2 respect to healthy pigs (p¼0.0001). CONCLUSIONS: Taken together these results suggest an underestimate role of ARPCS in preventing endothelial dysfuncton by the production of several proteins. The identification of these molecules may offer novel strategies to protect endothelial compartment and promote kidney repair. and renal failure. CKD is a major cause of morbidity and mortality, and renal fibrosis is an important common final pathway leading to the progression of CKD. Renal pericyte activation, accumulation and excessive extracellular matrix (ECM) production are the key events leading to renal tubulointerstitial fibrosis. Currently, there is no effective therapy to treat or reverse AKI to CKD transition, and it is critical to identify novel mediators of renal fibrosis to develop potential new therapeutics. Our laboratory has recently identified thioredoxin domain containing 5 (TXNDC5), an ER-resident protein with the enzyme activity of protein disulfide isomerase, as a critical mediator of cardiac fibrosis. The goal of this study is to test the hypothesis that TXNDC5 could also be involved in the pathogenesis of AKI to CKD transition and renal fibrosis. METHODS: Acute kidney injury was induced by unilateral Ischemia reperfusion injury (uIRI) in WT (C57BL/6) and Txndc5 -/-mice, followed by assays to quantify the extent of renal injury, inflammation and fibrosis 14 days and 28 days after the procedures. RESULTS: We have revealed that Txndc5 transcript was highly upregulated in mouse kidneys 14 days after uIRI; the expression level of Txndc5 also showed strong positive correlation with that of inflammatory chemokines and fibrogenic protein genes including Ccl2, Ccr2, Adgre1, Col1a1, Col3a1, Ctgf and Eln. Comparing to WT controls, mice with targeted deletion of Txndc5 produced less inflammatory cytokines/chemokines, developed much less renal fibrosis, and expressed significantly lower levels of ECM protein genes in the injured kidneys following uIRI. Immunofluorescent staining revealed that TXNDC5 is highly enriched in collagen-secreting pericytes in the renal interstitium. In addition, uIRI-induced TXNDC5 upregulation in renal pericytes was accompanied with increased JNK signaling activation, which is abolished by the genetic deletion of Txndc5. CONCLUSIONS: The present study revealed that TXNDC5 is a critical mediator of AKI-to-CKD transition and the development of post-injury renal fibrosis. TXNDC5 is required for uIRI-induced renal inflammation, pericyte activation and ECM production, likely through activating profibrotic JNK signaling. Targeting TXNDC5, therefore, could be a potential novel therapeutic approach to treat or prevent the progression of CKD following kidney injury. Biopsies are currently the only way to directly assess the renal tissue. Non-invasive measures would improve the understanding of this imbalanced turnover, and could potentially guide clinical decisions. In the current study we investigated the ability of non-invasive measures to assess the fibrogenic response upon ischemia/reperfusion injury (IRI). METHODS: A non-traumatic clamp was placed on both arteries of male Wistar rats for 45 min to induce ischemia, after which reperfusion was visually confirmed. The animals were followed for 1, 2 and 3 weeks. At each time-point a 23 Na Magnetic Resonance Imaging (MRI) sequence was carried out, samples taken and animals were subsequently euthanized. To assess the fibrogenic response, a-smooth muscle actin (aSMA), fibronectin (FN) and type III collagen (COL3) were assessed by quantitative polymerase chain reaction (qPCR) and western blots (WB) on extracts from the renal cortex. Two ELISAs detecting MMP-9 mediated degradation of COL3 (C3M) and the laminin 
